pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

6,918 products tracked · 6,918 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
  • Phase 2
    NEO-212
    Astrocytoma$NTHI NEONC TECHNOLOGIES HOLDINGS, INC.
  • NEOMYCIN AND POLYMYXIN B SULFATES AND DEXAMETHASONE
    NEOMYCIN AND POLYMYXIN B SULFATES AND DEXAMETHASONE (NEOMYCIN SULFATE, POLYMYXIN B SULFATE, AND DEXAMETHASONE)
    no indication BAUSCH AND LOMB
  • NEOMYCIN AND POLYMYXIN B SULFATES AND GRAMICIDIN
    NEOMYCIN AND POLYMYXIN B SULFATES AND GRAMICIDIN (NEOMYCIN SULFATE, POLYMYXIN B SULFATE AND GRAMICIDIN)
    no indication BAUSCH AND LOMB
← prev
page 112 of 231
next →
131
Pain89
Neurology1
NEOMYCIN AND POLYMYXIN B SULFATES, BACITRACIN ZINC AND HYDROCORTISONE
NEOMYCIN AND POLYMYXIN B SULFATES, BACITRACIN ZINC AND HYDROCORTISONE (NEOMYCIN SULFATE AND POLYMYXIN B SULFATE, BACITRACIN ZINC AND HYDROCORTISONE)
no indication
BAUSCH AND LOMB
  • NEOMYCIN POLYMYXIN B SULFATES AND DEXAMETHASONE
    NEOMYCIN POLYMYXIN B SULFATES AND DEXAMETHASONE (NEOMYCIN SULFATE, POLYMYXIN B SULFATE AND DEXAMETHASONE)
    no indication BAUSCH AND LOMB
  • NEOSTIGMINE
    NEOSTIGMINE
    no indication DR REDDYS
  • Preclinical
    NERx-329
    Lung Cancer NERx BioSciences Inc
  • Preclinical
    NES-100
    Cancer Pain Virpax Pharmaceuticals Inc
  • NESACAINE
    NESACAINE (CHLOROPROCAINE HYDROCHLORIDE)
    no indication FRESENIUS KABI USA
  • Preclinical
    NEU-001
    Hirschsprung Diseases (Congenital Aganglionic Megacolon) Neurenati Therapeutics
  • Phase 2
    NG-350A
    Epithelial Tumor Akamis Bio Ltd
  • Phase 2
    NGGT-002
    Phenylketonuria (PKU) Next Generation Gene Therapeutics Inc
  • Phase 3
    NGN-401
    Rett Syndrome$NGNE Neurogene Inc.
  • Preclinical
    NGoXIM
    NGoXIM
    Gonorrhea TherapyX Inc
  • Phase 1
    NIM-1324
    Rheumatoid Arthritis NImmune Biopharma Inc
  • NITROFURANTOIN MACROCRYSTALS
    NITROFURANTOIN MACROCRYSTALS
    no indication ALMATICA
  • NITROFURANTOIN MONOHYDRATE/ MACROCRYSTALLINE
    NITROFURANTOIN MONOHYDRATE/ MACROCRYSTALLINE (NITROFURANTOIN MONOHYDRATE/MACROCRYSTALLINE)
    no indication ALMATICA
  • NITROGEN
    NITROGEN
    no indication LINDE NORTH AMERICA INC
  • Preclinical
    NIV-001
    Stroke Neuro-Innovators LLC
  • NIVESTYM
    NIVESTYM (FILGRASTIM-AAFI)
    no indication Hospira Inc
  • Phase 1
    NKT-3964
    Adenocarcinoma Of The Gastroesophageal Junction NiKang Therapeutics Inc
  • Phase 1
    NLX-101
    Fragile X Syndrome Neurolixis Inc
  • Preclinical
    NM-1014
    Autism Spectrum Disorder (ASD) Nova Mentis BioTech Corp
  • Preclinical
    NM-1020
    Fragile X Syndrome Nova Mentis BioTech Corp
  • Phase 1
    NM-5072
    Paroxysmal Nocturnal Hemoglobinuria NovelMed Therapeutics Inc
  • Phase 1
    NM-6603
    Colorectal Cancer Nucmito
  • Phase 1
    NMS-812
    Refractory Acute Myeloid Leukemia Nerviano Medical Sciences SRL
  • Phase 1
    NN-3201
    Adenoid Cystic Carcinoma (ACC) Novelty Nobility Inc
  • Preclinical
    NNDA-001
    Parkinson's Disease Neoneuron LLC
  • Preclinical
    NNI-351
    Fragile X Syndrome NeuroNascent Inc